MIX2: A Novel Natural Multi-Component Modulator of Multidrug-Resistance and Hallmarks of Cancer Cells

被引:11
|
作者
Gawel, Agata M. [1 ]
Godlewska, Marlena [1 ]
Grech-Baran, Marta [2 ]
Stachurska, Anna [3 ]
Gawel, Damian [1 ]
机构
[1] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Marymoncka 99-103, PL-01813 Warsaw, Poland
[2] Polish Acad Sci, Inst Biochem & Biophys, Lab Plant Pathogenesis, Warsaw, Poland
[3] Ctr Postgrad Med Educ, Dept Immunohematol, Warsaw, Poland
来源
关键词
P-GLYCOPROTEIN; IN-VITRO; MEDICINE; REVERSAL; ADHESION; COMPLEMENTARY; TRANSPORTERS; INHIBITORS; EXTRACT; TRENDS;
D O I
10.1080/01635581.2018.1560480
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multidrug resistance is one of the key barriers suppressing the effectiveness of drug therapies of malignant tumors. Here, we report a study on the effect of a mix of natural extracts (MIX2) prepared from fresh fruits of Prunus spinosa, Crataegus monogyna, Sorbus aucuparia, and Euonymus europaeus on the classic hallmarks of cancer cells and the expression of multidrug resistance proteins. In the studies, HeLa and T98G cell lines, and classic methods of molecular biology, including RT-qPCR, Western blot, flow cytometry, and confocal imaging, were used. Additionally, migration, adhesion, and proliferation assays were performed. The obtained results indicate that the MIX2 cocktail presents strong anti-cancer properties. MIX2 is not toxic, but at the same time significantly alters the migration, proliferation, and adhesion of tumor cells. Furthermore, it was found that cells exposed to the mixture presented a significantly reduced expression level of genes associated with MDR, including ABCB1, which encodes for glycoprotein P. In vitro data showed that MIX2 effectively sensitizes tumor cells to doxorubicin. We postulate that modulation of the multidrug resistance phenotype of tumors with the use of MIX2 may be considered as a safe and applicable tool in sustaining drug delivery therapies of malignancies.
引用
收藏
页码:334 / 347
页数:14
相关论文
共 15 条
  • [1] Fallopia japonica, a Natural Modulator, Can Overcome Multidrug Resistance in Cancer Cells
    Eid, Safaa Yehia
    El-Readi, Mahmoud Zaki
    Ashour, Mohamed Lotfy
    Wink, Michael
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [2] Novel multidrug-resistance modulators, KR-30026 and KR-30031, in cancer cells
    Choi, SU
    Lee, BH
    Kim, KH
    Choi, EJ
    Park, SH
    Shin, HS
    Yoo, SE
    Jung, HP
    Lee, CO
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4577 - 4582
  • [3] Effects of KR-30035, a novel multidrug-resistance modulator, on the cardiovascular system of rats in vivo and on the cell cycle of human cancer cells in vitro
    Lee, BH
    Shin, HS
    Lee, CO
    Park, SH
    Yoo, SE
    Yi, KY
    Jung, NP
    Choi, SU
    ANTI-CANCER DRUGS, 2000, 11 (01) : 55 - 61
  • [4] HPLC DETERMINATION OF A NEW MULTIDRUG-RESISTANCE MODULATOR (S9788) EXTRACTED FROM CANCER-CELLS IN-VITRO
    TASSIN, JP
    DUBOIS, J
    HANOCQ, M
    ATASSI, G
    TALANTA, 1995, 42 (05) : 747 - 753
  • [5] Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells
    Fabio Fusi
    Antonella Ferrara
    Attila Zalatnai
    Joseph Molnar
    Giampietro Sgaragli
    Simona Saponara
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 443 - 451
  • [6] Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells
    Fusi, Fabio
    Ferrara, Antonella
    Zalatnai, Attila
    Molnar, Joseph
    Sgaragli, Giampietro
    Saponara, Simona
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (03) : 443 - 451
  • [7] A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer
    Ghosh, Ruma Dey
    Banerjee, Kaushik
    Das, Satyajit
    Ganguly, Avishek
    Chakraborty, Paramita
    Sarkar, Avijit
    Chatterjee, Mitali
    Choudhuri, Soumitra K.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 49 (04) : 737 - 747
  • [8] DERIVATIVES OF A NOVEL CYCLOPEPTOLIDE .2. SYNTHESIS, ACTIVITY AGAINST MULTIDRUG-RESISTANCE IN CHO AND KB CELLS IN-VITRO, AND STRUCTURE-ACTIVITY-RELATIONSHIPS
    EMMER, G
    GRASSBERGER, MA
    SCHULZ, G
    BOESCH, D
    GAVERIAUX, C
    LOOR, F
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (13) : 1918 - 1928
  • [9] The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2
    Skrypek, Nicolas
    Vasseur, Romain
    Vincent, Audrey
    Duchene, Belinda
    Van Seuningen, Isabelle
    Jonckheere, Nicolas
    ONCOTARGET, 2015, 6 (13) : 10853 - 10867
  • [10] Nrf2-driven up-regulation of glutamate cysteine ligase and multidrug-resistance protein 1 by 15-deoxy4#916;12,14_ prostaglandin J2 confers resistance to doxorubicin-induced apoptosis in human breast cancer cells
    Song, Na-Young
    Kim, Eun-Hee
    Kim, Do-Hee
    Na, Hye-Kyung
    Surh, Young-Joon
    CANCER RESEARCH, 2009, 69